Additionally, a successful sale would free up cash for management to deploy either in its continued effort to clean up the company's balance sheet, or to repurchase shares, or to pursue M&A opportunities in higher-growth segments. |
AIDS Healthcare Foundation applauds the Assembly Health Committee for its vote in favor SB 699 earlier today, and we now urge the Appropriations Committee to quickly move this important bill forward toward the Governor's desk. Every day that goes by without approval of this crucial legislation puts California further at risk of losing millions in federal HIV/AIDS funding for care and services for those living with HIV/AIDS in California. |
AIDS Healthcare Foundation applauds the California Senate for its timely and unanimous vote on SB 699 earlier today, and we fully expect the Assembly to quickly move this crucial piece of legislation on to the Governor's desk. We are heartened that the Senate recognized the urgency of this bill. Every day that goes by without approval of this legislation puts California further at risk of losing millions in federal HIV/AIDS funding for care and services for those living with HIV/AIDS in California. |
As for the sex club and bathhouse owners' disingenuous denial of what occurs in their clubs, this frivolous lawsuit further delays the roll out of these pretty prudent public health regulations and hampers even the most basic HIV and STD prevention efforts in these high-risk venues. The club owners will become a laughingstock as they try to defend this suit in court. |
As of right now, management guidance, in our view, appears reasonable. |
Brazil is one of the world leaders in AIDS prevention as well as in providing access to treatment and drugs. |
But we're not looking to replace Whitman-Walker if Whitman-Walker wants to continue to provide the service. |
By prevailing in the battle for Guidant, (Boston Scientific) has secured its future. |
Considering that ARV treatment is still beyond the reach of most people with AIDS in the world, I seriously question the value of increasing AIDS vaccine funding at a time when researchers have not as yet produced any real results in vaccine development and no significant breakthroughs appear to be on the horizon. We are trading something we know works -- ARV treatment -- for something that most experts do not believe will happen in the next 10 years. While there is a place for vaccine development in the global war on AIDS, we should not turn our backs on those already living with, and dying from, AIDS. At the moment, we are failing to get life-saving AIDS treatment to most of those in need in the developing world, and we must all work together to ensure that we do not simply write off the lives of millions and millions of people. |
Following today's announcement, we expect the Street to begin a process of revaluing Boston Scientific shares, resulting in a higher forward multiple, and despite a significant hit to future earnings, a natural upward bias to the shares. |
For the year, we had a positive performance from both operations and financial perspectives. |
I don't think this is a 20 percent growth market. I think it will have a hard time sustaining 15 percent in the next 5 years. |
I don't want people to think that because Stryker had encouraging commentary and is giving attractive guidance for 2006 that necessarily means that orthopedics are back. |
In addition, we hope to have a working '50s-type television studio. |
It's behind the times. Condoms in today's world are much more used for disease prevention than pregnancy prevention, |